Miragen Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Miragen Therapeutics Inc 's ROA in the second quarter of 2026?
Miragen Therapeutics Inc recorded a cumulative net loss of $-240 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -54.94%.

However, within the Healthcare sector 754 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2025 from to 4527.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Jun 30 2025) II. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Dec 31 2019) IV. Quarter
Y / Y Total Assets Change	3525.78 %	1400.33 %	-32.69 %	-39.06 %	641.06 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-240	-123	-33	-37	-42
Return On Assets (TTM)	-54.94 %	-72.34 %	-98.31 %	-96.94 %	-96.92 %
MGEN's Total Ranking	# 4527	#	# 5103	# 4649	# 4436
Total Assets (TTM) in million	1,097	582	33	33	30
Seq. Total Assets Change	88.42 %	1673.59 %	-1.95 %	10.65 %	-22.03 %
Seq. Net Income Change	-	-	-	-	-

MGEN's 5 Years Annual ROA >> Back to MGEN Management Effectiveness >> Compare MGEN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 34
Sector	# 755
Overall	# 4376

Return On Assets Statistics
High	Average	Low
-38.14 %	-70.77 %	-141.8 %
(Jun 30 2018)		(Sep 30 2016)

Financial Statements
Miragen Therapeutics Inc 's Assets	$ 1,097 million	MGEN's Balance sheet
Miragen Therapeutics Inc 's Income	$ -127 million	Quarterly MGEN's Income Statement
MGEN's Income by Division		See MGEN's Income by Division

Annual Return On Assets	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2016) FY 2016	(Dec 31 2015) FY 2015
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	30	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-42	-33	-27	-13	-11
Annual Return On Assets	-138.37 %	-	-	-	-

MGEN's 5 Years Annual ROA >> Back to MGEN Management Effectiveness >> Compare MGEN ROA to its Competitors

More Return On Assets Ratios
MGEN's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MGEN's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MGEN's Competitors
Subscribers only: Roa for Miragen Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for MGEN's Customers

You may also want to know
MGEN's Roi	MGEN's Inventory Turnover Ratio	MGEN's Growth Rates	MGEN's Dividend Comparisons
	MGEN's Profitability Ratios	MGEN's Asset Turnover Ratio	MGEN's Dividend Growth
MGEN's Roe	MGEN's Valuation Ratios	MGEN's Financial Strength Ratios	MGEN's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T06:14:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.